Outpatient parenteral antibiotic therapy: Principles and practice

European Journal of Internal Medicine

Volumn 24, Issue 7, 2013, Pages 617-623

  Seaton, R A ^a   Barr, D A ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

Ambulatory care; Bone and joint infection; Cellulitis; Endocarditis; Hospital at home

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CLINDAMYCIN; DAPTOMYCIN; ERTAPENEM; FLUCLOXACILLIN; TEICOPLANIN;

AMBULATORY CARE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BONE MARROW TOXICITY; CELLULITIS; CHOLESTASIS; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE ASSOCIATION; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG HYPERSENSITIVITY; DRUG MONITORING; ENDOCARDITIS; EVIDENCE BASED PRACTICE; FATIGUE; GOOD CLINICAL PRACTICE; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HEALTH SERVICE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL PATIENT; HUMAN; INFECTIOUS ARTHRITIS; INFUSION SYSTEM; INTERNIST; LEUKOPENIA; LOADING DRUG DOSE; LOEFFLER PNEUMONIA; MYOSITIS; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT MONITORING; PATIENT SAFETY; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCAL BACTEREMIA; TREATMENT DURATION; URINARY TRACT INFECTION;

AMBULATORY CARE; BONE AND JOINT INFECTION; CELLULITIS; ENDOCARDITIS; HOSPITAL AT HOME;

ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOME INFUSION THERAPY; HUMANS; INFUSIONS, PARENTERAL; OUTPATIENTS;

EID: 84884288990     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.03.014     Document Type: Review

References (47)

1. Health Protection Scotland Scottish national point prevalence survey of healthcare associated infection and antimicrobial prescribing 2011 2012 Health Protection Scotland [ http://www.documents.hps.scot.nhs.uk/hai/sshaip/ prevalence/report-2012-04.pdf ]
2. R.A. Seaton, D. Nathwani, P. Burton, C. McLaughlin, A.R. MacKenzie, and S. Dundas Point prevalence survey of antibiotic use in Scottish Hospitals; evaluation of the Glasgow Antimicrobial Audit Tool (GAAT) Int J Antimicrob Agents 29 2007 693 699
3. Department of health advisory committee on antimicrobial resistance and healthcare associated infection Antimicrobial stewardship: "Start smart - then focus" 2011 [ www.dh.gov.uk ]
4. R.W. Rucker, and G.M. Harrison Outpatient intravenous medications in the management of cystic fibrosis Pediatrics 54 1974 358 360
5. A.D. Tice Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA Eur J Clin Microbiol Infect Dis 14 1995 655 661
6. A.O. Wai, L. Frighetto, C.A. Marra, E. Chan, and P.J. Jewesson Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective Pharmacoeconomics 18 2000 451 457
7. B.P. Howden, and M.L. Grayson Hospital-in-the-home treatment of infectious diseases Med J Aust 176 2002 440 445
8. A. Upton, R.B. Ellis-Pegler, and A. Woodhouse Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital N Z Med J 117 2004 U1020
9. D.A. Fisher, A. Kurup, D. Lye, P.A. Tambyah, Z. Sulaiman, and E.Y. Poon Outpatient parenteral antibiotic therapy in Singapore Int J Antimicrob Agents 28 2006 545 550
10. S. Esposito, S. Leone, S. Noviello, F. Ianniello, M. Fiore, and M. Russo Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study J Chemother 19 2007 417 422
11. P.C. Matthews, C.P. Conlon, A.R. Berendt, J. Kayley, L. Jefferies, and B.L. Atkins Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years J Antimicrob Chemother 60 2007 356 362
12. A.L. Chapman, S. Dixon, D. Andrews, P.J. Lillie, R. Bazaz, and J.D. Patchett Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective J Antimicrob Chemother 64 2009 1316 1324
13. D. Nathwani, J. Morrison, R.A. Seaton, A.J. France, P. Davey, and K. Gray Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year's experience in Tayside Health Bull (Edinb) 57 1999 332 337
14. J. Hitchcock, A.P. Jepson, J. Main, and H.J. Wickens Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series J Antimicrob Chemother 64 2009 630 634
15. A.D. Tice, S.J. Rehm, J.R. Dalovisio, J.S. Bradley, L.P. Martinelli, and D.R. Graham Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines Clin Infect Dis 38 2004 1651 1672
16. G.A. Caplan, J.A. Ward, N.J. Brennan, J. Coconis, N. Board, and A. Brown Hospital in the home: a randomised controlled trial Med J Aust 170 1999 156 160
17. P. Corwin, L. Toop, G. McGeoch, M. Than, S. Wynn-Thomas, and J.E. Wells Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital BMJ 330 2005 129
18. S. Shepperd, H. Doll, R.M. Angus, M.J. Clarke, S. Iliffe, and L. Kalra Admission avoidance hospital at home Cochrane Database Syst Rev 2008 CD007491
19. S. Rehm, M. Campion, D.E. Katz, R. Russo, and H.W. Boucher Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy J Antimicrob Chemother 63 2009 1034 1042
20. R.M. Gesser, K.A. McCarroll, and G.L. Woods Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections J Infect 48 2004 32 38
21. A.L.N. Chapman, R.A. Seaton, M.A. Cooper, S. Hedderwick, V. Goodall, and C. Reed Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement J Antimicrob Chemother 67 2013 1053 1062
22. E. Lamont, R.A. Seaton, M. Macpherson, L. Semple, E. Bell, and A.H. Thomson Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme J Antimicrob Chemother 64 2009 181 187
23. Department of Health Review of prescribing, supply and administration of medicines Final Report 1999 Department of Health London, UK
24. R.A. Seaton, E. Bell, and Y. Gourlay Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone J Antimicrob Chemother 55 2005 764 767
25. R.A. Seaton, J. Morrison, I. Man, J. Watson, and D. Nathwani Outpatient parenteral antimicrobial therapy - a viable option for the management of cutaneous Leishmaniasis Q J Med 92 1999 659 667
26. D. Nathwani The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom Chemotherapy 47 2001 17 23
27. R.A. Seaton, E. Bell, V. Bezlyak, and C.J. Weir Factors associated with outcome and length of parenteral therapy in outpatient parenteral antibiotic therapy (OPAT) treated patients with skin and soft tissue infections Int J Antimicrob Agents 38 2011 243 248
28. J. Kayley, A.R. Berendt, M.J.M. Snelling, H. Moore, H.C. Hamilton, and T.E.A. Peto Safe intravenous therapy at home: experience of a UK based programme J Antimicrob Chemother 37 1996 1023 1029
29. C.L. Mackintosh, H.A. White, and R.A. Seaton Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service J Antimicrob Chemother 66 2011 408 415
30. C. Cervera, A. del Rio, L. Garcia, M. Sala, M. Almela, and C. Falces Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study Enferm Infecc Microbiol Clin 29 2011 587 592
31. C.J. Duncan, D.A. Barr, A. Ho, E. Sharp, L. Semple, and R.A. Seaton Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis J Antimicrob Chemother 2013 10.1093/jac/dkt046
32. A.D. Tice, K. Strait, R. Ramey, and P.A. Hoaglund Outpatient parenteral antimicrobial therapy for central nervous system infections Clin Infect Dis 29 1999 1394 1399
33. B. White, J.E. Coia, C. Sykes, H. Mathers, and R.A. Seaton Enteric fever in returning travellers: role of outpatient parenteral antibiotic therapy J Infect 64 2012 242 245
34. R. Bazaz, A.L. Chapman, and T.G. Winstanley Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms J Antimicrob Chemother 65 2010 1510 1513
35. E.S.R. Darley, K.E. Bowker, A.M. Lovering, J.E. Harvey, and A.P. MacGowan Meropenem 3 g once daily for outpatient treatment of infective exacerbations of bronchiectasis J Antimicrob Chemother 45 2000 247 250
36. B. White, R.A. Seaton, and T.J. Evans Review of suspected Lyme infection management via an outpatient parenteral antimicrobial therapy (OPAT) service Q J Med 106 2013 133 138
37. D. Nathwani, J. Sneddon, W. Malcolm, C. Wiuff, A. Patton, and S. Hurding Development and impact of the Scottish National Antimicrobial Stewardship Programme Int J Antimicrob Agents 38 2011 16 26
38. C.J. Duncan, D.A. Barr, and R.A. Seaton Outpatient parenteral antimicrobial therapy (OPAT) with ceftriaxone Int J Clin Pract 34 2012 410 417
39. W.J. Martone, K.C. Lindfield, and D.E. Katz Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry Int J Clin Pract 62 2008 1183 1187
40. R.A. Seaton, V.J. Gonzalez-Ramallo, V. Prisco, M. Marcano-Lozada, A. Gonzalez-Ruiz, and B. Gallegos Daptomycin for outpatient parenteral antibiotic therapy: a European registry experience Int J Antimicrob Agents 2013 10.1016/j.ijantimicag.2013.01.019
41. D.A. Barr, L. Semple, and R.A. Seaton Outpatient parenteral antimicrobial therapy in a teaching hospital based practice: a retrospective cohort study describing experience and evolution over 10 years Int J Antimicrob Agents 39 2012 407 413
42. M.L. Hoffman-Terry, H.S. Fraimow, T.R. Fox, B.G. Swift, and J.E. Wolf Adverse effects of outpatient parenteral antibiotic therapy Am J Med 106 1999 44 49
43. D.A. Barr, L. Semple, and R.A. Seaton Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study Eur J Clin Microbiol Infect Dis 31 2012 2611 2619
44. Y.M. Yan, M. Singh, K. Tonks, J. Kavi, and N.J. Langford Delivering outpatient antibiotic therapy (OPAT) in an Acute Medical Unit Acute Med 10 2011 22 25
45. H. Nguyen H Hospitalist to home: outpatient parenteral antimicrobial therapy at an academic centre Clin Infect Dis 51 2010 S220 S223
46. A.D. Tice Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins Drugs 59 2000 29 35
47. C. Yong, D.A. Fisher, G.E. Sklar, and S.-C. Li A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective Int J Antimicrob Agents 33 2009 46 51